Deep Brain Stimulation for Parkinson's Disease: the Globus Pallidus Internus Versus Subthalamic Nucleus
NCT ID: NCT02647372
Last Updated: 2017-08-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
30 participants
INTERVENTIONAL
2012-06-30
2018-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Combined Deep Brain Stimulation in Parkinson's Disease
NCT05415774
Subthalamic Nucleus Versus Globus Pallidal Internus Deep Brain Stimulation for Parkinson Disease
NCT07250685
Subthalamic Deep Brain Stimulation (DBS) in Parkinson's Disease
NCT02012647
Deep Brain Stimulation for Patients With Parkinson's Disease.
NCT03128567
Combined Deep Brain Stimulation for Parkinson's Disease
NCT01485276
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Endocrinological approach
Parkinson patient submitted to DBS surgery target to globus pallidus nucleus or the subthalamic nucleus. Those patients will be endocrinological evaluation including metabolic measures, calorimetric parameters.
Subthalamic nucleus
Surgery will be performed in 15 patients with DBS target to the subthalamic nucleus
Globus pallidus
Surgery will be performed in 15 patients with DBS target to the globus pallidus nucleus
Neurological approach
Parkinson patient submitted to DBS surgery target to globus pallidus nucleus or the subthalamic nucleus. Those patients will be neurological evaluation including UPDRS scale.
Subthalamic nucleus
Surgery will be performed in 15 patients with DBS target to the subthalamic nucleus
Globus pallidus
Surgery will be performed in 15 patients with DBS target to the globus pallidus nucleus
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Subthalamic nucleus
Surgery will be performed in 15 patients with DBS target to the subthalamic nucleus
Globus pallidus
Surgery will be performed in 15 patients with DBS target to the globus pallidus nucleus
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients who may be in the anesthetized or local or general anesthesia does not incur higher than expected risk in the general population.
* Patients intellectually able to understand and sign the consent form.
* Patients with hematological, metabolic and normal coagulation.
Exclusion Criteria
* Impossibility to consent to participate in the study.
* Patients during treatment with anti-coagulants or anti-platelet agents.
* Patients with anatomical abnormalities that preclude access to the implantation of electrodes (eg cranial tumors or intracranial or cysts).
* Patients with uncontrolled infection or other medical conditions pre-existing non-controlled (eg decompensated diabetes, hypertension, heart disease or symptomatic air).
* History of primary or secondary myocardial ischemia, congestive heart failure, cardiac arrhythmia or bundle branch block refractory to treatment.
* Concomitant treatment with other experimental drugs.
* Pregnant or lactating.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Sao Paulo
OTHER
Hospital Sirio-Libanes
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Erich Fonoff
MD, PhD
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HSL 2012/12
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.